Skip to main content

Advertisement

Log in

Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB/N female mice

  • Research Article
  • Published:
Biogerontology Aims and scope Submit manuscript

Abstract

FVB/N wild type and transgenic HER-2/neu FVB/N female mice breed at N.N. Petrov Research Institute of Oncology were under observation until natural death without any special treatment. Age-related dynamics of body weight, food consumption and parameters of carbohydrate and lipid metabolism, level of nitric oxide, malonic dialdehyde, catalase, Cu, Zn-superoxide dismutase, vascular endothelial growth factor were studied in both mice strains. The parameters of life span and tumor pathology were studied as well. Cancer-prone transgenic HER-2/neu mice developed in 100 % multiple mammary adenocarcinomas and died before the age of 1 year. Forty tree percent of long-lived wild type mice survived the age of 2 years and 19 %—800 days. The total tumor incidence in wild type mice was 34 %. The age-associated changes in the level of serum IGF-1, glucose and insulin started much earlier in transgene HER-2/neu mice as compared with wild type FVB/N mice. It was suggested that transgenic HER-2/neu involves in initiation of malignization of mammary epithelial cells but also in acceleration of age-related hormonal and metabolic changes in turn promoting mammary carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Anisimov VN (2001) Mutant and genetically modified mice as models for studying the relationship between aging and carcinogenesis. Mech Ageing Dev 122(12):1221–1255

    Article  CAS  PubMed  Google Scholar 

  • Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, Kovalenko IG, Poroshina TE, Semenchenko AV, Provinciali M, Re F, Franceschi C (2005) Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Exp Gerontol 40(8–9):685–693

    Article  CAS  PubMed  Google Scholar 

  • Anisimov VN, Egormin PA, Piskunova TS, Popovich IG, Tyndyk ML, Yurova MV, Zabezhinski MA, Anikin IV, Karkach AS, Romanyukha AA (2010a) Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle 9(1):188–197

    Article  CAS  PubMed  Google Scholar 

  • Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MN, Antoch MP, Blagosklonny MV (2010b) Rapamycin extends maximal life span in cancer-prone mice. Am J Pathol 176(5):1092–1096

    Article  Google Scholar 

  • Anisimov VN, Popovich IG, Zabezhinski MA (2013) Methods of testing pharmacological drugs effects on aging and life-span in mice. Methods Mol Biol 1048:145–160

    Article  CAS  PubMed  Google Scholar 

  • Baturin DA, Alimova IN, Anisimov VN, Popovich IG, Zabezhinski MA, Provinciali M, Mancini R, Franceschi C (2001) The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression. Neuroendocrinol Lett 22(6):441–447

    CAS  PubMed  Google Scholar 

  • Bazhanova ED, Molodsov VN, Popovich IG, Anisimov VN (2007) Apoptosis regulation in hypothalamic neurosceretory cells of hER2/neu transgenic mice in ontogenesis. Adv Gerontol 20(4):31–35

    CAS  PubMed  Google Scholar 

  • Goubler EV (1978) Computing methods of pathology analysis and recognition. Meditsina, Leningrad

  • Gupta K, Krishnaswamy G, Karnad A, Peiris AN (2002) Insulin: a novel factor in carcinogenesis. Am J Med Sci 323(3):140–145

    Article  CAS  PubMed  Google Scholar 

  • Gutierrez C, Schiff R (2011) HER2: biology, detection, and clinical implications. Arch Pathol Lab Med 135(1):55–62. doi:10.1043/2010-0454-RAR.1

    PubMed  PubMed Central  Google Scholar 

  • Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH (1993) FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14(11):2353–2358

    Article  CAS  PubMed  Google Scholar 

  • Huang P, Duda DG, Jain RK, Fukumura D (2008) Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB/N mice. Comp Med 5(3):253–263

    Google Scholar 

  • Ingram DK, Jucker M (1999) Developing mouse models of aging: a consideration of strain differences in age-related behavioral and neural parameters. Neurobiol Aging 20(2):137–415

    Article  CAS  PubMed  Google Scholar 

  • Liao C-Y, Kennedy BK (2014) Mouse models and aging: longevity and progeria. Curr Topics Dev Biol 109:249–285

    Article  Google Scholar 

  • Mahler JM, Stokes W, Mann PC, Takaoka M, Maronpot RR (1996) Spontaneous lesions in aging FVB/N mice (1996). Toxicol Pathol 24(6):710–716

    Article  CAS  PubMed  Google Scholar 

  • Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54(1):105–115

    Article  CAS  PubMed  Google Scholar 

  • Muller WJ, Ho J, Siegel PM (1998) Oncogenic activation of Neu/ErbB-2 in a transgenic mouse model for breast cancer. Biochem Soc Symp 63:149–157

    CAS  PubMed  Google Scholar 

  • Nadon NL (2006) Exploiting the rodent model for studies on the pharmacology of lifespan extension. Aging Cell 5(1):9–15

    Article  CAS  PubMed  Google Scholar 

  • Pierpaoli E, Viola V, Barucca A, Orlando F, Galli F, Provinciali M (2013) Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice. Carcinogenesis 34(6):1352–1360

    Article  CAS  PubMed  Google Scholar 

  • Raafat A, Strizzi L, Lashin K, Ginsburg E, McCurdy D, Salomon D, Smith GH, Medina D, Callahan R (2012) Effects of age and parity on mammary gland lesions and progenitor cells in the FVB/N-RC mice. PLoS One 7(8):e43624

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Radaelli E, Arnold A, Papanikolaou A, Garcia-Fernandez RA, Mattiello S, Scanziani E, Cardiff RD (2009) Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas. Vet Pathol 46(4):736–745. doi:10.1354/vp.08-VP-0280-R-FL

    Article  CAS  PubMed  Google Scholar 

  • Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Roderick TH, Stewart CL, Lilly F, Hansen CT et al (1991) FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci USA 88(6):2065–2069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Turusov VS, Mohr U (eds) (1994) Pathology of tumours in laboratory animals. Tumours of the mouse, IARC Sci Publ No 111, 2nd edn. IARC, Lyon

    Google Scholar 

  • Wakefield LM, Thordarson G, Nieto AI, Shyamala G, Galvez JJ, Anver MR, Cardiff RD (2003) Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med 53(4):424–432

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vladimir N. Anisimov.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Panchenko, A.V., Popovich, I.G., Trashkov, A.P. et al. Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB/N female mice. Biogerontology 17, 317–324 (2016). https://doi.org/10.1007/s10522-015-9611-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10522-015-9611-y

Keywords

Navigation